What is the current stock price of Elevation Oncology, Inc. (ELEV)?

As of the latest market data, Elevation Oncology, Inc. (ELEV) is trading at $0.36. The stock has seen a loss of -2.12% today.

Does Elevation Oncology, Inc. (ELEV) pay a dividend?

Based on current data, Elevation Oncology, Inc. does not have a confirmed active dividend policy.

What is the market cap of Elevation Oncology, Inc.?

The current market capitalization of Elevation Oncology, Inc. (ELEV) is approximately unavailable.

ELEV

Elevation Oncology, Inc.·Healthcare

0.37

2.119%(−0.01)

Market Closed

0.38

3.288%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.2252W H: $3.09

Company Profile

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-06-25

Beta

1.50

Websiteelevationoncology.com↗